Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 14641 | 54 |
09:34 ET | 3096 | 54 |
09:36 ET | 1140 | 54.185 |
09:38 ET | 250 | 54.15 |
09:39 ET | 100 | 53.85 |
09:41 ET | 850 | 53.83 |
09:43 ET | 151 | 53.785 |
09:45 ET | 1400 | 53.815 |
09:48 ET | 100 | 53.84 |
09:50 ET | 500 | 54 |
09:52 ET | 1178 | 53.895 |
09:54 ET | 3108 | 53.85 |
09:56 ET | 2173 | 53.7917 |
09:59 ET | 250 | 53.685 |
10:01 ET | 200 | 53.47 |
10:03 ET | 1586 | 53.43 |
10:06 ET | 1206 | 53.62 |
10:08 ET | 500 | 53.7 |
10:10 ET | 814 | 53.5 |
10:12 ET | 729 | 53.41 |
10:14 ET | 1705 | 53.52 |
10:15 ET | 1200 | 53.5 |
10:17 ET | 1321 | 53.5986 |
10:19 ET | 1000 | 53.385 |
10:21 ET | 1381 | 53.465 |
10:24 ET | 100 | 53.445 |
10:26 ET | 3358 | 53.41 |
10:28 ET | 2300 | 53.52 |
10:30 ET | 582 | 53.425 |
10:32 ET | 3779 | 53.4 |
10:33 ET | 644 | 53.275 |
10:35 ET | 200 | 53.17 |
10:37 ET | 904 | 52.95 |
10:39 ET | 500 | 53.1 |
10:42 ET | 255 | 53.08 |
10:44 ET | 400 | 53.03 |
10:46 ET | 400 | 53.17 |
10:48 ET | 100 | 53.17 |
10:50 ET | 587 | 53.11 |
10:51 ET | 650 | 53.14 |
10:55 ET | 1094 | 52.975 |
10:57 ET | 100 | 52.97 |
11:00 ET | 800 | 52.99 |
11:02 ET | 612 | 52.98 |
11:04 ET | 800 | 53.085 |
11:08 ET | 600 | 53.19 |
11:09 ET | 480 | 53.28 |
11:11 ET | 700 | 53.26 |
11:18 ET | 300 | 53.31 |
11:20 ET | 600 | 53.31 |
11:22 ET | 100 | 53.305 |
11:24 ET | 441 | 53.275 |
11:26 ET | 904 | 53.41 |
11:29 ET | 7724 | 53.63 |
11:31 ET | 200 | 53.74 |
11:33 ET | 600 | 53.835 |
11:36 ET | 3217 | 53.73 |
11:38 ET | 339 | 53.7 |
11:40 ET | 517 | 53.81 |
11:42 ET | 575 | 53.93 |
11:44 ET | 1049 | 53.955 |
11:45 ET | 9440 | 54.02 |
11:47 ET | 16167 | 54.24 |
11:49 ET | 100 | 54.235 |
11:51 ET | 500 | 54.31 |
11:54 ET | 1459 | 54.11 |
11:56 ET | 700 | 54.19 |
11:58 ET | 100 | 54.15 |
12:00 ET | 400 | 54.18 |
12:02 ET | 800 | 54.265 |
12:03 ET | 1575 | 54.075 |
12:05 ET | 610 | 54.075 |
12:07 ET | 100 | 54.08 |
12:09 ET | 2104 | 53.99 |
12:12 ET | 300 | 53.89 |
12:14 ET | 1213 | 53.95 |
12:16 ET | 1191 | 53.93 |
12:18 ET | 411 | 53.835 |
12:20 ET | 2847 | 53.61 |
12:21 ET | 2200 | 53.87 |
12:23 ET | 2840 | 53.61 |
12:25 ET | 500 | 53.365 |
12:27 ET | 400 | 53.49 |
12:30 ET | 2142 | 53.495 |
12:32 ET | 507 | 53.4 |
12:36 ET | 300 | 53.42 |
12:39 ET | 348 | 53.43 |
12:41 ET | 100 | 53.51 |
12:43 ET | 300 | 53.31 |
12:45 ET | 300 | 53.3 |
12:48 ET | 100 | 53.38 |
12:50 ET | 1405 | 53.03 |
12:52 ET | 3008 | 52.94 |
12:54 ET | 200 | 52.87 |
12:56 ET | 1100 | 52.86 |
12:57 ET | 1223 | 52.94 |
12:59 ET | 500 | 52.8 |
01:03 ET | 4431 | 52.705 |
01:06 ET | 1100 | 52.545 |
01:08 ET | 10532 | 52.6 |
01:10 ET | 200 | 52.52 |
01:12 ET | 2656 | 52.6 |
01:14 ET | 900 | 52.535 |
01:15 ET | 1683 | 52.555 |
01:17 ET | 200 | 52.555 |
01:21 ET | 2106 | 52.645 |
01:26 ET | 3616 | 52.78 |
01:28 ET | 1107 | 52.885 |
01:30 ET | 1261 | 52.75 |
01:32 ET | 1058 | 52.805 |
01:33 ET | 300 | 52.8 |
01:35 ET | 200 | 52.71 |
01:37 ET | 1277 | 52.8075 |
01:39 ET | 100 | 52.785 |
01:42 ET | 740 | 52.64 |
01:44 ET | 100 | 52.56 |
01:48 ET | 854 | 52.44 |
01:50 ET | 1089 | 52.55 |
01:51 ET | 963 | 52.49 |
01:53 ET | 200 | 52.53 |
01:57 ET | 100 | 52.585 |
02:02 ET | 1599 | 52.6 |
02:04 ET | 725 | 52.68 |
02:06 ET | 571 | 52.73 |
02:08 ET | 951 | 52.68 |
02:09 ET | 300 | 52.63 |
02:11 ET | 2418 | 52.62 |
02:13 ET | 149 | 52.645 |
02:15 ET | 300 | 52.575 |
02:18 ET | 1400 | 52.48 |
02:20 ET | 328 | 52.37 |
02:22 ET | 700 | 52.3 |
02:24 ET | 4847 | 52.65 |
02:26 ET | 200 | 52.685 |
02:27 ET | 1000 | 52.84 |
02:29 ET | 501 | 52.97 |
02:31 ET | 200 | 52.88 |
02:36 ET | 200 | 52.88 |
02:38 ET | 934 | 52.91 |
02:44 ET | 110 | 52.84 |
02:45 ET | 512 | 52.89 |
02:47 ET | 2891 | 53.07 |
02:49 ET | 1920 | 52.91 |
02:54 ET | 337 | 52.865 |
02:56 ET | 400 | 52.9 |
02:58 ET | 789 | 52.87 |
03:00 ET | 300 | 52.89 |
03:02 ET | 200 | 52.87 |
03:03 ET | 100 | 52.9 |
03:05 ET | 300 | 52.685 |
03:07 ET | 100 | 52.545 |
03:12 ET | 3471 | 52.665 |
03:16 ET | 2179 | 52.75 |
03:18 ET | 200 | 52.75 |
03:20 ET | 2018 | 52.72 |
03:21 ET | 200 | 52.7 |
03:23 ET | 716 | 52.565 |
03:27 ET | 2043 | 52.6 |
03:30 ET | 100 | 52.65 |
03:32 ET | 1067 | 52.72 |
03:34 ET | 100 | 52.71 |
03:36 ET | 980 | 52.68 |
03:38 ET | 800 | 52.68 |
03:39 ET | 700 | 52.84 |
03:41 ET | 1583 | 52.9 |
03:43 ET | 1870 | 52.94 |
03:45 ET | 877 | 52.86 |
03:48 ET | 850 | 52.82 |
03:50 ET | 904 | 52.75 |
03:52 ET | 1224 | 52.765 |
03:54 ET | 900 | 52.88 |
03:56 ET | 1650 | 52.88 |
03:57 ET | 3385 | 52.88 |
03:59 ET | 75267 | 52.99 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.3B | -14.1x | --- |
Immunovant Inc | 4.3B | -15.2x | --- |
Avidity Biosciences Inc | 4.9B | -14.3x | --- |
BridgeBio Pharma Inc | 4.9B | -10.1x | --- |
Biohaven Ltd | 3.7B | -4.3x | --- |
Madrigal Pharmaceuticals Inc | 5.1B | -9.2x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.1x |
Price/Sales (TTM) | 3,117.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.